MENU
NSPR
AS OF
Feb 6 closing price
Price
$1.74
Change
+$0.10 (+6.10%)
Capitalization
73.73M
30 days until earnings call
Intraday BUY SELL Signals
+Compare
NSPR
Stock ticker: NASDAQ
AS OF
Feb 6 closing price
Price
$1.74
Change
+$0.10 (+6.10%)
Capitalization
73.73M

NSPR InspireMD Forecast, Technical & Fundamental Analysis

InspireMD Inc is a United States based medical device company... Show more

NSPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NSPR with price predictions
Feb 06, 2026

NSPR's RSI Indicator ascending out of oversold territory

The RSI Oscillator for NSPR moved out of oversold territory on January 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where NSPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 06, 2026. You may want to consider a long position or call options on NSPR as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NSPR just turned positive on January 27, 2026. Looking at past instances where NSPR's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NSPR advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NSPR broke above its upper Bollinger Band on February 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NSPR entered a downward trend on January 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.150) is normal, around the industry mean (11.235). P/E Ratio (0.000) is within average values for comparable stocks, (37.951). NSPR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.616). NSPR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (12.531) is also within normal values, averaging (38.320).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NSPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NSPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NSPR is expected to report earnings to rise 11.76% to -18 cents per share on March 10

InspireMD NSPR Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.08
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.09
Q4'24
Beat
by $0.01
The last earnings report on November 04 showed earnings per share of -17 cents, beating the estimate of -25 cents. With 19.52K shares outstanding, the current market capitalization sits at 73.73M.
A.I. Advisor
published General Information

General Information

a developer of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
4 Menorat Hamaor Street
Phone
+972 36917691
Employees
66
Web
https://www.inspiremd.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYBQF1.94N/A
N/A
Cyberdyne Inc.
PTAUY13.37N/A
N/A
Port of Tauranga Ltd.
SPCOQ0.19N/A
N/A
The Stephan Co.
BMKDF0.36-0.01
-1.46%
Biomark Diagnostics Inc.
GLPEF19.92-0.99
-4.75%
Galp Energia, SA

NSPR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NSPR has been loosely correlated with ARAY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NSPR jumps, then ARAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSPR
1D Price
Change %
NSPR100%
+6.10%
ARAY - NSPR
44%
Loosely correlated
+3.32%
MXCT - NSPR
43%
Loosely correlated
N/A
OM - NSPR
43%
Loosely correlated
+2.51%
ABT - NSPR
41%
Loosely correlated
+1.60%
VVOS - NSPR
41%
Loosely correlated
+3.33%
More

Groups containing NSPR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSPR
1D Price
Change %
NSPR100%
+6.10%
Medical/Nursing Services
industry (218 stocks)
3%
Poorly correlated
+1.94%
Health Services
industry (413 stocks)
-0%
Poorly correlated
+2.27%